Melanomas; Trials show immune drugs effective in advanced melanomas
Melanomas; Trials show immune drugs effective in advanced melanomas
About this item
Full title
Melanomas; Trials show immune drugs effective in advanced melanomas
Publisher
Atlanta: NewsRx
Journal title
Biotech Week, 2015, p.1636
Language
English
Formats
Publication information
Publisher
Atlanta: NewsRx
Subjects
More information
Scope and Contents
Contents
In the phase III trial CheckMate 067, the combination of nivolumab with ipilimumab shows, "better efficacy but more toxicity," [Rene Gonzalez] says, suggesting that the combination might be most appropriate for patients whose melanomas do not over-express the protein PDL1, which can be targeted by other drugs. "Maybe PDL1-negative patients will ben...
Alternative Titles
Full title
Melanomas; Trials show immune drugs effective in advanced melanomas
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1687148562
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1687148562
Other Identifiers
ISSN
1535-2757
E-ISSN
1537-1395
How to access this item
Log in as a Library member
